Long Island housing market remains hot as winter sets in

first_imgNorth Babylon homes listed for sale (Douglas Elliman)Median home prices in Suffolk and Nassau counties hit record highs in November, thanks in large part to low mortgage rates, according to Newsday.Suffolk County’s median sales price was $472,500, up 18.4 percent from November 2019. That trend appears to be continuing, as pending sale prices were up 16 percent year-over-year. The number of sales was 19 percent higher.Nassau County’s median sales price hit $598,000, up 11.9 percent year-over-year, and pending sales prices were up 14 percent. Home sales were up by nearly a third compared to last year.Properties regularly attract dozens of prospective homebuyers and sell above ask. For example, a four-bedroom home in North Babylon sold for $50,000 above its roughly $500,000 asking price. The owners paid less than $400,000 for it just three years ago.Both counties came to a standstill during lockdowns starting in March, but quickly recovered in the months when restrictions on real estate activity were lifted. The rate for a 30-year fixed mortgage has hovered around 3 percent since this summer. This content is for subscribers only.Subscribe Nowlast_img read more

More consumers read email on the move

first_img ShareShareSharePrintMailGooglePinterestDiggRedditStumbleuponDeliciousBufferTumblr by. Georgann SmithWhen formulating an email marketing strategy, keep this in mind: Desktops and laptops are taking a backseat to mobile devices as consumers’ preferred method for checking email.In fact, according to email marketing firm Movable Ink’s U.S. Consumer Device Preference Report: Q4 2013 only 35 percent of emails were opened on desktop PCs, down from 39 percent in just the previous quarter. Smartphones accounted for 48 percent of email opens and tablets accounted for 17 percent. For marketing emails, the number opened on a smartphone is even higher. Nearly 65 percent of marketing emails were opened on a mobile device in the fourth quarter 2013. That’s up from 61 percent in the previous quarter.“This report…shows that we are in the midst of a mobile takeover,” writes Vivek Sharma, co-founder and CEO of Movable Ink. She added, “We expect marketers to continue to place high priority on mobile optimization, which will allow them to better engage consumers who are on-the-go with relevant, real-time offers.”These statistics drive home the importance for financial institution marketers to consider the mobile channel when reaching out to consumers. This means more than simply optimizing the message for a smaller screen; it requires thinking holistically about when, why and how the consumer will interact with your communication and what call-to-action can realistically be expected from on-the-go consumers. continue reading »last_img read more

Switch to oral antibiotics in bacteremia not tied to worse outcomes

first_imgA study led by researchers from Johns Hopkins University School of Medicine suggests that patients with Enterobacteriaceae bloodstream infections who’ve shown clinical improvement can be transitioned from intravenous (IV) to oral antibiotic therapy without compromising patient outcomes. The findings appeared yesterday in JAMA Internal Medicine.In the retrospective cohort study involving nearly 1,500 patients with Enterobacteriaceae bacteremia, the researchers found no difference in 30-day mortality or recurrence of bacteremia between patients who received oral step-down antibiotic therapy within the first 5 days of IV treatment and those who continued to receive IV antibiotics. In addition, the patients who were transitioned to oral therapy were able to leave the hospital 2 days sooner.Comparable outcomes but shorter staysThe multicenter study included patients at three hospitals—the Johns Hopkins Hospital, the Hospital of the University of Pennsylvania, and the University of Maryland Medical Center—who were treated for monomicrobial Enterobacteriaceae bloodstream infections from 2008 through 2014. Study participants had at least one positive blood culture for Enterobacteriaceae commonly recovered from bloodstream infections, including Citrobacter species, Enterobacter species, Escherichia coli, Klebsiella species, Proteus mirabilis, or Serratia marcescens.To be eligible for the study, patients had to have the source of the infection controlled within the first 5 days, appropriate clinical response by day 5, active antibiotic therapy from day 1 until discontinuation, availability of an in vitro active oral antibiotic agent, and ability to consume other oral medications by day 5. In addition, patients had to have a Pitt bacteremia score—a measure of severity of illness—of 1 or lower by day 5.Patients who were transitioned to oral therapy were less likely to be severely ill at the onset of their infection and more likely to have complex underlying conditions.Outcomes included 30-day all-cause mortality, 30-day recurrent bloodstream infection with the same organism, and duration of hospitalization from day 1 of bacteremia until hospital discharge.Using propensity-score matching to account for patient differences, the researchers grouped 1,478 patients on a 1:1 basis into the study’s two arms, with 739 patients in the oral step-down group and 739 in the IV group. Patients in the oral step-down group received a median of 3 days of IV therapy, while patients in the IV group received a median of 14 day of IV therapy.Sources of bacteremia in the patients included urine (594 patients [40.2%]), gastrointestinal tract (297 [20.1%]), central line-associated (272 [18.4%]), pulmonary (58 [3.9%]), and skin and other soft-tissue infections (41 [2.8%]).Analysis of the outcomes demonstrated 97 deaths (13.1%) in the oral step-down group within 30 days, compared with 99 (13.4%) in the IV group (hazard ratio [HR], 1.03; 95% confidence interval [CI], 0.82 to 1.30), and 6 episodes (0.8%) of recurrent bacteremia within 30 days in the oral therapy group versus 4 (0.5%) in the IV group (HR, 0.82; 95% CI, 0.33 to 2.01). The median time from day 1 of bacteremia to hospital discharge was 5 days in the oral step-down group versus 7 days in the IV group (HR, 0.98; 95% CI, 0.97-1.00; P < .001).Benefits of oral therapyAlthough the researchers did not evaluate why the patients who continued on IV therapy remained in the hospital for 2 days longer than those who transitioned to oral therapy, they suggest the extra days could reflect the reluctance of clinicians to send patients home with peripherally inserted central catheters, difficulties associated with arranging outpatient parenteral antibiotic therapy, and the challenges of placing patients in post-acute care facilities.But that finding is in line with previous research, which has shown that transitioning patients to oral antibiotics can improve patient quality of life by reducing length of hospital stays and eliminating the discomfort associated with IV catheters. Oral therapy is also associated with decreased risk for catheter-associated adverse events and reduced healthcare costs.The authors of the study conclude, "Until a clinical trial is performed, our findings suggest that oral step-down therapy is not associated with inferior clinical outcomes for patients with Enterobacteriaceae bacteremia who have received appropriate source control and demonstrated an appropriate clinical response compared with patients who continue to receive IV therapy for the duration of their treatment course."See also:Jan 22 JAMA Internal Med studylast_img read more

Sky Cable ditches Bingawan exhibition; Hercor takes over

first_imgHERCOR College Jaguars was tapped to replace Sky Cable-Iloilo in a basketball exhibition match against University of Santo Tomas Growling Tigers on June 19 at the Bingawan National High School in Bingawan, Iloilo.Sky Cable backed out, with most of its players committed to the Maharlika Pilipinas Basketball League.“Sky Cable informed us that they cannot field a team against UST because most of their players are committed to the MPBL. Iyong mga teams, ayaw ipahiram iyong players for the exhibition,” Mayor Mark Palabrica told Panay News.“We are glad that Hercor accepted our invitation to play against UST. It will definitely be an interesting matchup,” he added. “Hercor can also attract Ilonggos to watch the game.” Jaguars will not be a pushover when it plays against Tigers – it recently made things difficult for De La Salle University Green Archers during their exhibition match in Capiz – Palabrica assured.Jaguars will field Julius David Jr., Jesan Dela Cruz, John Vincent Duran, Lovermon Lustria, Errol Micael Ordinaria, Ronilo Parohinog Jr., King Philip John Quibrantar, Prince Unayan, Robinson Witzinger, and Kenneth Tulipas.The Jaguars-Growling Tigers exhibition match will be played after the championship game of the 2018 Bingawan Foundation Cup Season 2 High School Basketball Premier Tournament on Tuesday./PNlast_img read more